Faecal microbial transplantation (FMT) was pioneered as a licenced medicine by Professor Hawkey and his team at the University of Birmingham
An innovative treatment for patients with Clostridium difficile infection (CDI) which uses transplanted gut bacteria to treat the infection, is a more effective and more cost-efficient treatment than using antibiotics, a new UK study has found.
CDI is an infection of the bowel, which commonly affects people who have recently been treated in hospital, those with underlying conditions and patients over 65. Almost 30 per cent of patients treated for the condition experience at least one recurrence. A recurrence of the condition, has been associated with a higher risk of mortality and is usually treated using antibiotics.
Faecal microbial transplantation (FMT), a treatment pioneered as a licenced medicine by Professor Peter Hawkey and his team at the University of Birmingham, is a method where gut bacteria and other components in faeces are used to treat CDI. The bacteria is taken from a screened healthy donor, processed and screened before being transplanted via a tube passed through the nose into the stomach. Treatment with FMT is associated with higher cure and lower recurrence rates than fidaxomicin or vancomycin- the two most common antibiotics used to treat recurrent CDI (rCDI).
The study, which presents the first decision model for patients with rCDI already hospitalised in the UK, analysed randomised controlled trials, observational studies and expert opinion from the UK, on patients with single or multiple rCDI. Researchers analysed the cost of each of the four treatment options for rCDI for treatment effects, unit costs, resource and health related quality of life to identify which treatment was the most cost-effective and offered the best outcome for patients.
The study showed that both methods for administering FMT were lower in cost compared to standard treatment with antibiotics. FMT via naso-gastric tube was the least costly, with a mean cost of £8,877 per patient, while FMT via colonoscopy was £11,716 per patient. FMT via colonoscopy was also shown to be slightly more effective than treatment via naso-gastric tube, offering patients a higher quality of life. Two other standard antibiotic treatments vancomycin and fidaxomicin were compared in the model but both these treatments were shown to be more costly and less effective than either of the FMT interventions. Moreover, Vancomycin was the most expensive and the least effective treatment.
Professor Peter Hawkey, formerly of the University of Birmingham said, “We at the University of Birmingham pioneered this treatment as the UK’s first third party FMT service. FMT is not currently a widespread treatment for this disease but by showing that it not only saves lives, but is also significantly more cost effective, we hope that this could be one of the first steps towards the treatment being accepted more widely.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Clostridium difficile infection
- Hospital Acquired Infection Control Market Value Forecasted To Reach US$ 7.8 Billion By 2028 Covering Covid-19 Impact: Acumen Research And Consultingon August 18, 2021 at 6:34 am
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Hospital Acquired Infection Control Market – Global Industry Analysis, Market Size, ...
- Clostridium Diagnostics Market Research Report Includes Size, Capacity, Production, Revenue, Gross Margin, Forecast to 2027on August 17, 2021 at 4:32 am
Aug 17, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" “Clostridium Diagnostics Market” ...
- Two Tyler hospitals retain four-star ratings in latest reporton August 17, 2021 at 3:45 am
Stars were gained and lost across East Texas in new, updated annual hospital ratings from the Center for Medicare and Medicaid Services.
- Delayed ileostomy closure increases odds of Clostridium Difficile infection: Studyon August 15, 2021 at 8:30 pm
A diverting ileostomy is typically performed to divert intestinal contents in high-risk colorectal anastomoses. Ileostomy closure is associated with high rates of post-operative ...
- Vancouver-area health officials train dog team to sniff out COVID-19on August 12, 2021 at 9:08 am
A health authority with a history of using dogs to help detect medical conditions has found a way to use its canine scent detection team to sniff out COVID-19.
Go deeper with Google Headlines on:
Clostridium difficile infection
Go deeper with Bing News on:
Faecal microbial transplantation
- Coral transplantation helps, but not the only solutionon August 18, 2021 at 3:43 am
All carry out coral transplantation projects in varied capacities ... near the coastline due to the presence of pollution and faecal matter in the water,” he explained.He added that the ...
- Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientson August 12, 2021 at 5:00 pm
Baruch et al. and Davar et al. report first-in-human clinical trials to test whether fecal microbiota transplantation (FMT) can affect how metastatic melanoma patients respond to anti–PD-1 ...
- Gastroenterology newson August 11, 2021 at 5:00 pm
A high-fat diet disrupts the biology of the gut's inner lining and its microbial communities—and promotes the production of a metabolite that may contribute to heart disease, according to a ...
- Faecal transplants from young to old mice prevent cognitive declineon August 9, 2021 at 9:11 am
When it comes to rejuvenating the bacteria balance in humans, researchers say a dietary alternative to a faecal transplant may present a more ... turned back the clock' in the old mice - and open up ...
- Faecal transplant trial aims to reduce discomfort felt by people with Parkinson's diseaseon July 28, 2021 at 2:32 pm
said the study of faecal microbiota transplantation (FMT) is an important step in microbial drug development. "Constipation is a common problem for many people with Parkinson's and has a wider ...